V-01-351/V-01D bivalence vaccine

· Livzon Pharmaceutical Group Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V-01-351/V-01D bivalence vaccine, covering 2022-03-10 to 2022-03-10. Get the full timeline:

Most recent: Clinical Trial Update: The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine [Phase 2]